학술논문

A phase 2/3 study of romiplostim N01 in chemotherapy-induced thrombocytopenia (CIT).
Document Type
Article
Source
Journal of Clinical Oncology. 2024 Supplement 10, Vol. 20, p217-217. 9p.
Subject
Language
ISSN
0732-183X